Fisher & Paykel Healthcare expects to make after-tax profit of up to $385 million this financial year, as its sales continue to spike as the medical sector battles with Covid-19.
The Auckland-based medical devices company, one of the world’s largest makers of products to treat chronic and
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
